Global Mumps Vaccine Market Research Report 2024(Status and Outlook)

Global Mumps Vaccine Market Research Report 2024(Status and Outlook)



Report Overview:

The MMR vaccine isa vaccine against measles, mumps, and rubella (German measles). The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least 4 weeks between the doses.

The Global Mumps Vaccine Market Size was estimated at USD 376.77 million in 2023 and is projected to reach USD 455.15 million by 2029, exhibiting a CAGR of 3.20% during the forecast period.

This report provides a deep insight into the global Mumps Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Mumps Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Mumps Vaccine market in any manner.

Global Mumps Vaccine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

MedImmune

Johnson & Johnson

Merck & Co., Inc.

Sanofi

Serum Institute of India

Bavarian Nordic

Astellas Pharma India

CSL Limited

Emergent BioSolutions

GlaxoSmithKline

Panacea Biotec, Ltd.

Biological E Limited

Bharat Biotech Ltd.

Novavax, Inc.

Novartis

Sinovac Biotech, Ltd.

Incepta Vaccine Limited

Valneva SE

VBI Vaccines

PT Bio Farma

Sharp & Dohme Corp

Bionity

Market Segmentation (by Type)

Child

Adult

Market Segmentation (by Application)

Hospitals Pharmacies

Retail Pharmacies

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Mumps Vaccine Market

Overview of the regional outlook of the Mumps Vaccine Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Mumps Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Mumps Vaccine
1.2 Key Market Segments
1.2.1 Mumps Vaccine Segment by Type
1.2.2 Mumps Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Mumps Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Mumps Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Mumps Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Mumps Vaccine Market Competitive Landscape
3.1 Global Mumps Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Mumps Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Mumps Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Mumps Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Mumps Vaccine Sales Sites, Area Served, Product Type
3.6 Mumps Vaccine Market Competitive Situation and Trends
3.6.1 Mumps Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Mumps Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Mumps Vaccine Industry Chain Analysis
4.1 Mumps Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Mumps Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Mumps Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Mumps Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Mumps Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Mumps Vaccine Price by Type (2019-2024)
7 Mumps Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Mumps Vaccine Market Sales by Application (2019-2024)
7.3 Global Mumps Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Mumps Vaccine Sales Growth Rate by Application (2019-2024)
8 Mumps Vaccine Market Segmentation by Region
8.1 Global Mumps Vaccine Sales by Region
8.1.1 Global Mumps Vaccine Sales by Region
8.1.2 Global Mumps Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Mumps Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Mumps Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Mumps Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Mumps Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Mumps Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 MedImmune
9.1.1 MedImmune Mumps Vaccine Basic Information
9.1.2 MedImmune Mumps Vaccine Product Overview
9.1.3 MedImmune Mumps Vaccine Product Market Performance
9.1.4 MedImmune Business Overview
9.1.5 MedImmune Mumps Vaccine SWOT Analysis
9.1.6 MedImmune Recent Developments
9.2 Johnson and Johnson
9.2.1 Johnson and Johnson Mumps Vaccine Basic Information
9.2.2 Johnson and Johnson Mumps Vaccine Product Overview
9.2.3 Johnson and Johnson Mumps Vaccine Product Market Performance
9.2.4 Johnson and Johnson Business Overview
9.2.5 Johnson and Johnson Mumps Vaccine SWOT Analysis
9.2.6 Johnson and Johnson Recent Developments
9.3 Merck and Co., Inc.
9.3.1 Merck and Co., Inc. Mumps Vaccine Basic Information
9.3.2 Merck and Co., Inc. Mumps Vaccine Product Overview
9.3.3 Merck and Co., Inc. Mumps Vaccine Product Market Performance
9.3.4 Merck and Co., Inc. Mumps Vaccine SWOT Analysis
9.3.5 Merck and Co., Inc. Business Overview
9.3.6 Merck and Co., Inc. Recent Developments
9.4 Sanofi
9.4.1 Sanofi Mumps Vaccine Basic Information
9.4.2 Sanofi Mumps Vaccine Product Overview
9.4.3 Sanofi Mumps Vaccine Product Market Performance
9.4.4 Sanofi Business Overview
9.4.5 Sanofi Recent Developments
9.5 Serum Institute of India
9.5.1 Serum Institute of India Mumps Vaccine Basic Information
9.5.2 Serum Institute of India Mumps Vaccine Product Overview
9.5.3 Serum Institute of India Mumps Vaccine Product Market Performance
9.5.4 Serum Institute of India Business Overview
9.5.5 Serum Institute of India Recent Developments
9.6 Bavarian Nordic
9.6.1 Bavarian Nordic Mumps Vaccine Basic Information
9.6.2 Bavarian Nordic Mumps Vaccine Product Overview
9.6.3 Bavarian Nordic Mumps Vaccine Product Market Performance
9.6.4 Bavarian Nordic Business Overview
9.6.5 Bavarian Nordic Recent Developments
9.7 Astellas Pharma India
9.7.1 Astellas Pharma India Mumps Vaccine Basic Information
9.7.2 Astellas Pharma India Mumps Vaccine Product Overview
9.7.3 Astellas Pharma India Mumps Vaccine Product Market Performance
9.7.4 Astellas Pharma India Business Overview
9.7.5 Astellas Pharma India Recent Developments
9.8 CSL Limited
9.8.1 CSL Limited Mumps Vaccine Basic Information
9.8.2 CSL Limited Mumps Vaccine Product Overview
9.8.3 CSL Limited Mumps Vaccine Product Market Performance
9.8.4 CSL Limited Business Overview
9.8.5 CSL Limited Recent Developments
9.9 Emergent BioSolutions
9.9.1 Emergent BioSolutions Mumps Vaccine Basic Information
9.9.2 Emergent BioSolutions Mumps Vaccine Product Overview
9.9.3 Emergent BioSolutions Mumps Vaccine Product Market Performance
9.9.4 Emergent BioSolutions Business Overview
9.9.5 Emergent BioSolutions Recent Developments
9.10 GlaxoSmithKline
9.10.1 GlaxoSmithKline Mumps Vaccine Basic Information
9.10.2 GlaxoSmithKline Mumps Vaccine Product Overview
9.10.3 GlaxoSmithKline Mumps Vaccine Product Market Performance
9.10.4 GlaxoSmithKline Business Overview
9.10.5 GlaxoSmithKline Recent Developments
9.11 Panacea Biotec, Ltd.
9.11.1 Panacea Biotec, Ltd. Mumps Vaccine Basic Information
9.11.2 Panacea Biotec, Ltd. Mumps Vaccine Product Overview
9.11.3 Panacea Biotec, Ltd. Mumps Vaccine Product Market Performance
9.11.4 Panacea Biotec, Ltd. Business Overview
9.11.5 Panacea Biotec, Ltd. Recent Developments
9.12 Biological E Limited
9.12.1 Biological E Limited Mumps Vaccine Basic Information
9.12.2 Biological E Limited Mumps Vaccine Product Overview
9.12.3 Biological E Limited Mumps Vaccine Product Market Performance
9.12.4 Biological E Limited Business Overview
9.12.5 Biological E Limited Recent Developments
9.13 Bharat Biotech Ltd.
9.13.1 Bharat Biotech Ltd. Mumps Vaccine Basic Information
9.13.2 Bharat Biotech Ltd. Mumps Vaccine Product Overview
9.13.3 Bharat Biotech Ltd. Mumps Vaccine Product Market Performance
9.13.4 Bharat Biotech Ltd. Business Overview
9.13.5 Bharat Biotech Ltd. Recent Developments
9.14 Novavax, Inc.
9.14.1 Novavax, Inc. Mumps Vaccine Basic Information
9.14.2 Novavax, Inc. Mumps Vaccine Product Overview
9.14.3 Novavax, Inc. Mumps Vaccine Product Market Performance
9.14.4 Novavax, Inc. Business Overview
9.14.5 Novavax, Inc. Recent Developments
9.15 Novartis
9.15.1 Novartis Mumps Vaccine Basic Information
9.15.2 Novartis Mumps Vaccine Product Overview
9.15.3 Novartis Mumps Vaccine Product Market Performance
9.15.4 Novartis Business Overview
9.15.5 Novartis Recent Developments
9.16 Sinovac Biotech, Ltd.
9.16.1 Sinovac Biotech, Ltd. Mumps Vaccine Basic Information
9.16.2 Sinovac Biotech, Ltd. Mumps Vaccine Product Overview
9.16.3 Sinovac Biotech, Ltd. Mumps Vaccine Product Market Performance
9.16.4 Sinovac Biotech, Ltd. Business Overview
9.16.5 Sinovac Biotech, Ltd. Recent Developments
9.17 Incepta Vaccine Limited
9.17.1 Incepta Vaccine Limited Mumps Vaccine Basic Information
9.17.2 Incepta Vaccine Limited Mumps Vaccine Product Overview
9.17.3 Incepta Vaccine Limited Mumps Vaccine Product Market Performance
9.17.4 Incepta Vaccine Limited Business Overview
9.17.5 Incepta Vaccine Limited Recent Developments
9.18 Valneva SE
9.18.1 Valneva SE Mumps Vaccine Basic Information
9.18.2 Valneva SE Mumps Vaccine Product Overview
9.18.3 Valneva SE Mumps Vaccine Product Market Performance
9.18.4 Valneva SE Business Overview
9.18.5 Valneva SE Recent Developments
9.19 VBI Vaccines
9.19.1 VBI Vaccines Mumps Vaccine Basic Information
9.19.2 VBI Vaccines Mumps Vaccine Product Overview
9.19.3 VBI Vaccines Mumps Vaccine Product Market Performance
9.19.4 VBI Vaccines Business Overview
9.19.5 VBI Vaccines Recent Developments
9.20 PT Bio Farma
9.20.1 PT Bio Farma Mumps Vaccine Basic Information
9.20.2 PT Bio Farma Mumps Vaccine Product Overview
9.20.3 PT Bio Farma Mumps Vaccine Product Market Performance
9.20.4 PT Bio Farma Business Overview
9.20.5 PT Bio Farma Recent Developments
9.21 Sharp and Dohme Corp
9.21.1 Sharp and Dohme Corp Mumps Vaccine Basic Information
9.21.2 Sharp and Dohme Corp Mumps Vaccine Product Overview
9.21.3 Sharp and Dohme Corp Mumps Vaccine Product Market Performance
9.21.4 Sharp and Dohme Corp Business Overview
9.21.5 Sharp and Dohme Corp Recent Developments
9.22 Bionity
9.22.1 Bionity Mumps Vaccine Basic Information
9.22.2 Bionity Mumps Vaccine Product Overview
9.22.3 Bionity Mumps Vaccine Product Market Performance
9.22.4 Bionity Business Overview
9.22.5 Bionity Recent Developments
10 Mumps Vaccine Market Forecast by Region
10.1 Global Mumps Vaccine Market Size Forecast
10.2 Global Mumps Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Mumps Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Mumps Vaccine Market Size Forecast by Region
10.2.4 South America Mumps Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Mumps Vaccine by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Mumps Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Mumps Vaccine by Type (2025-2030)
11.1.2 Global Mumps Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Mumps Vaccine by Type (2025-2030)
11.2 Global Mumps Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Mumps Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Mumps Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings